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ABSTRACT 
 
Isolation and control of bodily substances is an important aspect of pre-hospital emergency 
care.  Proper decontamination is required to ensure safe working and transporting environments 
for both the healthcare provider and patient on the ambulance.  Current methods for disinfecting 
the ambulance and its respective equipment after calls have room for improvement.  We have 
collaborated with Worcester Emergency Medical Service (WEMS) paramedics to identify the 
need for better cleaning procedures, and therefore equipment that are better designed to remove 
contaminants. Common pathogenic risks present to both Emergency Medical Service (EMS) 
personnel and their patients were analyzed. Appropriate decontamination procedures and 
personal protective equipment were researched.  Alternative and effective disinfection methods 
and equipment along with preventative measures were considered and recommended. 
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CHAPTER 1. EMS AND LIFE-SAVING PRACTICES 
1. Introduction 
Emergency Medical Service (EMS) has existed in the United States for over 97 years, going 
as far back as volunteer squads in World War I.  Since then, many changes have been made that 
are significant improvements to the EMS system. These include the development of national 
standards for pre-hospital emergency care, the development of federal guidelines for ambulance 
design and installed equipment, and the adoption of proper emergency care procedures for each 
municipality, district or county in the US.  However the aforementioned advances are only a few 
of the nation-wide changes made to EMS protocol; many other improvements have been made in 
different aspects of the system, such as equipment design and the medical science.  However, 
there are still a handful of shortcomings to the EMS system that endangers both the patient and 
the provider in the field that need to be addressed. 
Amongst the many different issues in today’s EMS system – ranging from ergonomic 
problems to contamination threats – the most serious is the constant pathogenic risk to which 
both the worker and patients are exposed.  This project aims to identify shortcomings to the 
contamination prevention aspect of the EMS system, not only to bring public attention to the 
neglected problem, but to also propose solutions to it.   In order to adequately address said threat 
we have collaborated with Worcester Emergency Medical Service (WEMS) paramedics to 
identify them.  Of the many issues discussed, isolation and control of bodily substances were of 
universal concern amongst all healthcare providers but face greater limitations in a mobile and 
fast-paced environment such as in the ambulance.  Proper decontamination is required to ensure 
safe working and transportation environments for both the healthcare provider and patient in the 
ambulance.  However, thorough decontamination can take time, and on many occasions 
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emergency calls can pile on top of each other, thus requiring ambulances to respond with 
minimal cleaning.  Our project has two major goals: (1) to research and recommend designs for 
better body substance isolation systems and (2) to revise current cleaning procedures by the use 
of alternative equipment that effectively remove and prevent further accumulation of pathogens. 
This project investigates the many findings we have researched, not only to address them, 
but to propose solutions that we hope may one day be implemented.  Chapter 1 is the 
introduction of the research and project. Chapter 2 includes some history and necessary 
background to the EMS system.  It then describes current pathogenic risks present to both the 
emergency care technician and the patient. The chapter delves into the different modes of 
transmission and the types of pathogens present that are a current or a potential threat.  Chapter 2 
ends with a brief presentation of documented cases of occupational exposures among health care 
workers to such pathogens and currently available decontamination methods.  Chapter 3 includes 
a discussion of new technology that could detect and even identify pathogens, which may one 
day be practical in a pre-hospital setting. It then introduces different solutions and 
recommendations we make to minimize contamination issues for both the emergency care 
technician and the patient.  The chapter then analyzes the mentioned solutions for viability and 
practicality in a pre-hospital setting, concluding with our final recommendation for lowering 
pathogenic risk. Finally, chapter 4 summarizes the whole of our research and investigation, and 
identifies potential shortcomings of our project while suggesting areas in which further research 
might be beneficial.  
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CHAPTER 2. EMS AND PATIENT-CENTRIC QUALITY CARE 
2. Introduction 
An important aspect of emergency medical service (EMS) is to provide appropriate and 
adequate care for the patients.  Their condition must be stabilized and transported before 
conditions deteriorate rapidly.  The presence of pathogens inside an ambulance, however, not 
only poses a threat to the workers but also has the potential of worsening the patients’ condition 
and potentially leading to complications.  This is of particular interest in an age where anti-
microbialcides and other sanitizing agents are being extensively used.   Many children are more 
prone to diseases that were once less of an issue (Edge, M. J., et al., [1]).  Early exposure to 
pathogens provides anamnestic response to secondary exposure (Crowther, R. J., [2]), but not 
every patient is guaranteed to be immune to many pathogens, thus reinforcing the need for 
efficient sanitization methods for all persons present in the ambulance. 
Our project plays an important role in an attempt to pave the path for better patient-centered 
quality care.  Patients are transported in a small environment, which provides an excellent arena 
of transmission for many different types of contaminants.  Pathogens on the stretcher and other 
medical gear that have not been adequately decontaminated pose a threat to not only the 
healthcare providers in the ambulance, but also to the patient.  The need to provide a clean 
environment is critical.  To fully understand the current state of the EMS system, it is necessary 
to know some history of how it developed. 
The EMS system started off as organized volunteer squads in World War I, using motorized 
vehicles to transport injured soldiers.  Later in World War II, military trained corpsmen provided 
basic care and transport to field hospitals staffed by physicians and nurses.  By the time of the 
Korean War, field medics were trained and deployed along with medevac helicopters to transport 
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the wounded to nearby Mobile Army Surgical Hospital units where immediate emergency care 
was provided.  Such advances were unfortunately solely for the military and quality of 
emergency care for the sick and injured back home varied as late as the early 1960s.  Certain 
locations had ambulance services that were provided by well-trained personnel, similar to 
modern ambulances and equipment.  A few places had prehospital emergency care provisioned 
by hospital interns.  However, ambulance services in most places were provided by police, fire or 
local funeral homes that would convert their hearses or wagons to carry a cot.  Not surprisingly, 
ambulance services were primarily for transport and no formal provision for prehospital 
emergency care existed.  Quite often, patients with an acute illness were transported by their 
relatives and met with their family physician or on-call hospital physician because not all 
hospitals back then were staffed for emergency medical care (Pollak, N. A., [3]). 
In 1966, the publication Accidental Death and Disability: The Neglected Disease of Modern 
Society by the Institute of Medicine brought to attention the serious inadequacy of pre-hospital 
emergency care and transportation in many areas of the United States.  As a result, Congress 
mandated the National Highway and Traffic Safety Administration (NHTSA) of the Department 
of Transportation (DOT) and the Department of Health and Human Services (DHHS) to address 
the issues mentioned in the publication through the Highway Safety Act of 1966 and the 
Emergency Medical Act of 1973.  Some of the nationwide improvements made were (Pollak, N. 
A., [3]): 
1) Development of national courses of instruction for EMS, Fire, and Police personnel. 
2) Development of nationally accepted textbooks and training aids for said courses. 
3) Development of federal guidelines for ambulance design and equipment carried. 
4) Development and adoption of service guidelines. 
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5) Adoption of proper emergency care procedures for each municipality, district or county 
in the US. 
6) Establishment of hospital emergency departments that are adequately staffed with 
physicians, nurses and other personnel trained in emergency medicine. 
In the early 1970s, the DOT developed the first National Standard Curriculum for EMT training.  
Supporting the national curriculum, the American Academy of Orthopaedic Surgeons (AAOS) 
published the first EMT textbook in 1971, Emergency Care and Transportation of the Sick and 
Injured.  In the late 1970s to early 1980s the National Standard Curriculum was expanded to 
encompass paramedic training.   By 1980, Emergency Medical Service was established 
throughout the nation.  The system was based on two key features: 1) The responsibility of each 
municipality, township, or county to provide proper pre-hospital care and transport; and 2) the 
recognition of standards and regulations for training of emergency care technicians.  Throughout 
the 1980s higher levels of care were added to the National Standard Curriculum in what is now 
known as Advance Life Support (ALS) and Basic Life Support (BLS) (Pollak, N. A., [3]). 
 
2.1 Levels of Care 
In most states of the Unites State of America, there are 2 different levels of care: Advanced 
Life Support (ALS) and Basic Life Support (BLS).  Each emergency medical technician 
certification falls under one of the levels of care.  An EMT-Basic (EMT-B) or First Responder 
will fall under BLS, while EMT-Intermediate (EMT-I) or EMT-Paramedic (EMT-P) will fall 
under ALS (Pollak, N. A., [3]).  Not every state has all four levels of certification and some have 
very specific certifications. One such example is the EMT-Cardiac in the State of Rhode Island, 
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which specializes in dealing with cardiac related emergencies and the reading of a 12-lead 
electrocardiogram (EKG) (Lapierre, R. J., [4]). 
First responders, as the name indicates, are usually the first people on scene who initiate care.  
Police officers, fire fighters, park rangers, ski patrollers and other rescuers are often first 
responder certified, if not EMT certified.  They provide the immediate care to stabilize the 
patient and to pass him or her on to the next level of care.  The next level of certification is the 
EMT-B, who has an extensive knowledge and training for providing basic emergency care in the 
field.  They are trained to provide basic support to treat the patient in the field or to stabilize the 
patient for transport.  Moving from BLS to ALS, the first level of certification is the EMT-I.  An 
EMT-I has added ALS training to assist with paramedics and to better stabilize the patient.  
Some procedures an EMT-I is allowed to perform are IV therapy preparation, manual 
defibrillation, cardiac rhythm interpretation, and orotracheal intubation.  At the paramedic level, 
it is almost like having the ER in the field.  An EMT-P is capable of not only IV therapy, but also 
needle cricothyroidotomy, needle decompression for tension pneumothorax and many other 
medication therapies (Pollak, N. A., [3]).  This diverse availability of care ensures efficient and 
proper provision for the patient (a list of levels of care and their respective certifications can be 
found in Appendix A). 
 
2.2 Components of EMS 
There are many components to the EMS system that are critical for successful provision of 
care.  The first component of the system is access.  Access to the system is essential for it to 
work, and much advancement to this has been made starting with the switch from the 9-1-1 
system to the enhanced 9-1-1 system.  Global positioning systems and cellular triangulation 
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systems have also been incorporated in to the 9-1-1 system to efficiently identify the caller’s 
location to provide quick response to their needs.  Next, medical direction and control is needed 
to provide effective care.  Because EMTs are not doctors, they cannot diagnose or prescribe 
medication.  They are not trained to diagnose a condition, and so they must rather treat the 
eminent condition and transfer care to the hospital where the patient will receive definitive care.  
Medical control allows for both online and offline consultation for EMTs to effectively provide 
care.  Offline medical control is in the form of protocols specific to the local EMS system, while 
online medical control is a direct communication line to a physician medical director at a 
hospital who can give orders to be performed on his or her behalf.  This is key, especially when 
the administration of a certain medication is indicated.  However, an EMT must never provide 
care that is beyond their certification and has to remember his or her limitations (Pollak, N. A., 
[3]). 
 
2.3 Potential Communicable Pathogens 
As the initial step in patient care, pre-hospital care is vital for maintaining patient health and 
providing timely treatment.  Due to their frequent use and insufficient time for sterilization 
between transports, ambulances are prone to contamination, and pose a significant risk for the 
patients and the emergency medical technicians (EMTs) on board.  Among the ten most common 
symptoms in patients transported by an ambulance to emergency rooms, five involve the 
potential exposure to bodily fluids, which often carry multiple disease causing pathogens and can 
infect a healthcare personnel (Pollak, N. A., [3]). 
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Prevention is important, especially through the use of PPEs, however EMTs will greatly 
benefit from installations of pathogen detection systems in each ambulance.  Such systems will 
provide quick identification of pathogens and help with selection of appropriate PPEs and 
decontamination procedures after calls.  Enzyme Linked Immuno Sorbent Assays (ELISA) are 
currently available on the market for both home and laboratory use in the form of either a urine 
dipstick or 96-well plates.  An example of a commonly used ELISA for non-laboratory use is the 
pregnancy test.  ELISAs are a biochemical technique that is highly efficient in detecting the 
presence of an antibody or an antigen in a given sample.  Because of the specificity of ELISAs 
toward an antigen, multiple ELISAs would need to be carried out to detect the presence of 
common pathogens.  ELISA is also a time consuming technique that requires extensive 
preparation (Crowther, R. J, [2]).  Based on similar principles of ELISA, automated biosensors 
detect disease antigens or antibodies without the manual labor required for ELISA.  
 
2.3.1 Modes of Transmission 
The first area to explore in contaminant identification involves transmission types as they 
pertain to the ambulance. There are many different types of transmission, but for the purposes of 
the project the types investigated were Direct, Indirect, Airborne, and Droplet.  Protection 
against every mode of transmission varies from simple to heavy-duty PPEs.  Simple PPEs are 
often enough to protect the health care worker from many pathogens, but depending on the 
severity of the pathogens, a higher class PPE may be necessary like the one shown in Figure 4. 
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before infecting a new host is longer. Droplet transmission is a form of contact transmission and 
is similar to airborne transmission, but it occurs at closer range and thus, more quickly. The 
general rule of thumb for droplet transmission is that the transmission must occur within one 
meter from the mouth after exit, otherwise it is considered to be airborne transmission. Typically, 
this entails being sneezed, spit, or coughed on (Pollak, N. A., [3]). 
 
2.3.2 Bloodborne Pathogens 
Of the pathogenic risks present for healthcare professionals, bloodborne pathogens are the 
most prominent and serious of contaminants.  To list all bloodborne pathogens would be 
excessive; therefore the most common and high risk probable pathogens were selected and 
researched.  The first category of most common pathogens includes Human Immunodeficiency 
Virus (HIV), which may lead to Acquired Immune Deficiency Syndrome (AIDS), Hepatitis B 
Virus (HBV), Hepatitis C Virus (HCV), and Hepatitis D Virus (HDV).  The latter category of 
high risk pathogens includes Malaria, West Nile Virus, Viral Hemorrhagic Fevers (Ebola and 
Lassa). Although they are not common, they may be of serious concern due to efficient travel 
methods, notably air travel, and over use of antibiotics.  
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activated immediately.  Such treatment may take as long as 28 weeks and have a follow up 
period of up to 6 months.  Nevertheless, postexposure prophylaxis has an 81% likelihood for 
patients to remain with HIV-negative serum. Healthcare personnel exposed to bodily fluids from 
their patients are indicated to go through postexposure prophylaxis if the patient is known to be 
HIV-positive with a high viral load, if the patient is known to be HIV-positive with a low viral 
load, or if the HIV seroconversion status is unknown.  However, even if postexposure 
prophylaxis is indicative, it is a huge mental and physical burden on the victim and reported rates 
of adherence to medication are generally in the range of 70% to 80%.  Much of the drugs used 
have side effects including, but not limited to, potential nephrotoxicity, nausea, asthenia, 
neutropenia, anemia, abnormal liver-enzyme levels, diarrhea and other gastrointestinal side 
effects.  Patients going through postexposure prophylaxis should have their medical condition, 
especially hepatic condition monitored.  HIV testing is indicated throughout the treatment and 
also during a follow-up (Landovits, R. J., [7]). 
Chronic viral hepatitis was researched next.  HBV is the second most common cause of 
acute viral hepatitis after HCV.  HBV risks are greatly increased with healthcare personnel who 
may be in contact with blood.  There are approximately 1.2 million carriers in the United States.  
Many hospitals and ambulance services require that their employees be vaccinated for HBV.  
When exposure to the virus is suspected, immediate testing using rapid Enzyme-Linked 
Immunosorbent Assay for Hepatitis B surface antigen (HBsAg) is indicated along with 
postexposure prophylaxes.  HCV is the most prominent with about 3.2 million carriers in the 
United States.  There are several major HCV subtypes found in varying geographic locations that 
differ in virulence and response to therapy.  They also have the ability to alter their amino acid 
sequence
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pathogens include West Nile Virus and malaria. These diseases are typically transmitted through 
mosquito bites, however, one might also contact these diseases through blood transfusions or 
needle pricks (Pealer, L. M. [10]). For West Nile Virus, there were a total of 547 cases reported 
in the United States during 2010, with 22 deaths, according to the CDC. Oftentimes, there are no 
symptoms exhibited, although in some cases, patients present with cold or flu-like symptoms 
such as mild fever, headache, and chills. Detection for West Nile Virus is done by polymerase 
chain-reaction assay (Pealer, L. M., [10]), and in order to prevent the disease, it is best to take 
anti-mosquito measures and to be cautious around infected individuals. For those infected with 
West Nile Virus, there is no vaccine or direct treatment available, and so general supportive care 
is usually given.  
Malaria is a more serious disease, and although it has been for the most part eradicated in the 
United States, it is a serious problem in many other countries. On average, only 1500 cases are 
reported in the United States (Freedman, D. O., [11]).  In infected individuals, the disease can 
attack the liver and if left untreated, can be fatal (Okie, S., [12]). The symptoms for malaria are 
chills, fever, sweating, nausea, vomiting, and diarrhea. As the disease attacks the liver, symptoms 
such as jaundice and anemia can also be present (Freedman, D. O., [11]). In order to test for the 
disease, a blood test is often conducted to observe the presence of the malaria parasite. There is 
no vaccine to prevent the disease, although anti-mosquito measures and anti-malaria drugs are 
effective (Okie, S., [12]). To safeguard medical workers working with malaria patients, 
Universal Precautions by OSHA should be observed. 
Another type of bloodborne pathogen that can be dangerous for medical workers is those 
among the Viral Hemorrhagic Fevers (VHFs). Although not all VHFs can be transmitted by 
contact with blood, two serious diseases that can be transmitted this way are the Ebola and Lassa 
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Viruses. These diseases are quite uncommon, but some research has been dedicated to them due 
to the fear that they might be used as biological weapons. The Ebola Virus falls under the 
filoviridae family of VHFs, and has been known to infect humans and non-human primates. 
There have been no reported cases in the United States; however, there have been serious 
sporadic outbreaks on the African continent. This disease can be acquired through both Direct 
and Indirect Transmission. The symptoms for Ebola are fever, headache, muscle and joint pains, 
sore throat, weakness, vomiting, diarrhea, and stomach pains. In some patients, rash, red eyes, 
and internal and external bleeding is present (Albert, R. K., [5]). In order to test for the Ebola 
Virus, ELISAs and Polymerase Chain Reaction (PCR) tests can be performed. Because so little 
is known about this virus, there are no vaccines or direct treatments.  Supportive care involving 
balance of the patient’s fluids and electrolytes and responding to complications that arise from 
internal and external bleeding is all that can done.  For medical workers, use of Personal 
Protective Equipment (PPE) is strongly advised, along with avoidance of direct contact with the 
infected person if possible (Peters, C. J., [13]). 
The Lassa Virus falls under the Arenaviridae family of VHFs. It is estimated that there are 
100,000 to 300,000 infected individuals in West Africa. Although the virus’ natural carrier is the 
Mastomys rodent, this disease can also be transmitted through Direct or Indirect transmission. 
Patients with Lassa Virus may exhibit fever, retrosternal pain (pain behind the chest wall), sore 
throat, back pain, cough, abdominal pain, vomiting, diarrhea, conjunctivitis, facial swelling, 
proteinuria (protein in the urine), and mucosal bleeding. In addition, certain neurological 
problems may be present (Albert, R. K., [5]). Testing for Lassa Virus typically entails use of 
ELISAs or RT-PCR. Like the Ebola Virus, there is no vaccine or direct treatment, although 
antiviral drugs such as Ribavirin can be used along with supportive care. Lassa Virus prevention 
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remain viable for a long time increasing the probability of infection (Pollak, N. A., [3]).  
However careless and extensive use of antibiotics has led to Multi-Drug-Resistant TB (MDR 
TB), which is a pressing problem in many countries worldwide (Keshavjee, S., [15]).   
Table 1 - The Prevalence of Latent Tuberculosis Infection 
Group Expected Prevalence % (95% CI) 
Foreign-born persons 18.7 
Close contacts of persons with infectious 
tuberculosis 
37.1 
Homeless persons 22.6 
Injection-drug users 20.1 
Prisonsers 9.4 
 
Table 1 illustrates the percent prevalence of residents in the Unites States that have latent 
tuberculosis.  Latent tuberculosis has the potential of progressing from latent active disease, thus 
placing others at risk for contracting the disease.  More than 80% of tuberculosis cases in the 
U.S. are the result of latent TB infection progressing to the full disease.   Unfortunately, there is 
no way to detect the presence of latent TB in any individual patient and a detailed medical 
history along with skin test results must be interpreted to compute the probability of latent TB.   
A new diagnostic testing method for latent tuberculosis has recently come on the market and has 
potential for effective detection of latent TB.  QuantiFERON-TB Gold and T-SPOT.TB tests are 
both interferon-γ-release assays (IGRAs) and measure interferon-γ levels secreted from cells in 
vitro.  Cells obtained from the patient are exposed to purified protein derivatives (PPD) from M. 
tuberculosis and interferon-γ secretion from sensitized lymphocytes are monitored (Horsburgh, 
R. C., and Rubin E. R., [16]). 
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Table 2 – Prevalence of Latent Tuberculosis Progression to Active Disease 
Risk Factor Relative Risk % (95% CI) 
Advanced, untreated HIV infection 9.7 
Close contact with a person with infection 
tuberculosis 
6.1 
Radiographic evidence of old, healed 
tuberculosis that was not treated 
5.2 
Treatment with ≥15 mg of prednisone per day 2.8 
Chronic renal failure 2.4 
Treatment with TNF-α inhibitor 2.0 
Poorly controlled diabetes 1.7 
Weight ≥10% below normal 1.6 
Smoking 1.5 
  
Table 2 demonstrates the relative risks of latent TB progressing in to the active disease for each 
population group.  The top three risk groups are patients who have advanced, untreated HIV, 
patients who have had close contact with a person infected with TB or a patient who had 
radiographic evidence of old, healed TB that was not treated. 
Chickenpox is caused by the varicella-zoster family of viruses, and seems benign for 
children, but can be serious for adults.  It causes rashes and fever, which in many patients can 
range from mild to severe.  Influenza, also known as the flu, is widely prevalent.  It often 
presents as a severe cold with headaches, joint pain, fever, sore throat and even nausea (Albert, R. 
K., [5]).  If overlooked, the condition can worsen rapidly and possibly even lead to death.  
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from either masks shows enhanced barrier that prevents the forward movement of the coughs, 
which could travel 1 to 2 meters if not wearing one (Tang, J. W. and Settles, G. [17]). 
 
2.3.4 Other Pathogens 
The pathogens mentioned thus far are not the only types that pose a threat to those working 
in emergency medicine.  The mode of transmission for these are either direct or indirect contact 
and of most concern within the healthcare industries are Methicillin-resistant Staphylococcus 
aureus (MRSA), Vancomycin-resistant S. aureus (VRSA), and Clostridium difficile (CDF).  
These pathogens are often times transmitted through bed sheets of hospitals, however since 
ambulances use sheet-like material for their stretchers, it still possesses potential for 
contamination and transmission.  Intravascular catheters are also a common location of S. aureus 
infection.  Skin infections of S. aureus, MRSA and VRSA are the most common form of the 
disease.  In a hospital situation, such cases are dealt by either disinfecting the contaminated 
objects or replacing them.  Patients are treated with antibiotics as illustrated in the Table 3 
(Albert, R. K., [5]). 
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Table 3 – Treatments for patients infected with S. aureus. 
Infection Drugs 
Community-acquired cutaneous infections 
(non-MRSA) 
Dicloxacillin or cephalexin 250-500mg po q 6 
h for 7-10 days 
Penicillin-allergic patients with Community-
acquired cutaneous infections (non-MRSA) 
Erythromycin 250-500mg po q 6 h; 
clarithromycin 500mg po q 12 h; azithromycin 
500mg po on the 1st day then 250mg po q 24 h 
or clindamycin 300 mg po q 8 h 
Serious infections that are unlikely to be 
MRSA 
Nafcillin or oxacillin 1-2 g IV q 4-6 h or 
cefazolin 1 g IV q 8 h 
Penicillin-allergic patients with Serious 
infections that are unlikely to be MRSA 
Clindamycin 600 mg IV q 8 h or vancomycin 
15mg/kg q 12 h 
Serious infections with high likelihood of 
being MRSA 
Vancomycin 15 mg/kg IV q 12 h or linezolid 
600 mg IV q 12 h 
Documented MRSA By reported sensitivities 
Vancomycin-resistant staphylococci 
(Note: no clinical data, but listed drugs appear 
to be active in vitro – doses not established) 
Linezolid 600 mg IV q 12 h; quinupristin plus 
dalfopristin 7.5 mg/kg q 8 h; daptomycin 4 
mg/kg q 24 h 
 
Treatment for MRSA, or VRSA depends on the patients condition and seriousness of infections.  
The first two rows (non-MRSA) of Table 3 illustrate the use of oral antibiotics rather than IV 
antibiotic therapy, as is the case for the remaining rows – MRSA or VRSA infections. 
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2.4 Documented Occupational Exposures 
Although one large motivator for this project has been to reduce the time needed to clean 
and decontaminate the ambulance, another significant reason for the project has been to try and 
reduce instances of occupational exposure to pathogens. Occupational exposure in the ambulance 
setting can occur through exposure to bodily fluids or from inhalation of pathogens from the 
patient. Typically, exposure of bodily fluids is characterized by “percutaneous injury caused by a 
contaminated needle or other sharp object, contact with mucous membranes or non-intact skin, 
or contact with intact skin when involving extensive areas for a long period of time” (Marino, C. 
G. G., [18]).  
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Table 4 - Reported Exposures to Bloodborne Viruses among Healthcare Workers. 
 Percutaneous Mucotaneous Bites/Scratches/
Unknown 
No. of Incidents 
Nurses/Midwive
s 
210 82 16 308
Doctors 200 41 14 255
Healthcare 
Assistants 
20 5 4 29
Laboratory 
Workers 
9 5 0 14
Dentists 11 0 0 11
Phlebotomists 8 1 0 9
Dental 
Hygienists/Nurse
s 
5 0 3 8
Paramedics 2 3 1 6
Radiographers 2 3 1 6
Operating 
Department/Thea
ter Assistants 
4 1 0 5
Technicians 5 0 0 5
Porters 1 3 1 5
Others 6 7 4 17
Not Known  85 35 15 135
 
Table 4 was constructed using 813 reports of health care workers in the United Kingdom. 
Although the majority of health care workers that become exposed to contaminated bodily fluids 
typically work in the hospital setting, the recorded instances of paramedics being exposed to 
bloodborne viruses are not insignificant (Evans, B., [19]). It is interesting to note, however, that 
some observers note that many accidents involving exposure “often happen during cases of 
emergency”. As one hospital room emergency doctor describes from a past personal experience, 
“It was so urgent, the blood was spewing, what can you do? You can only stop the bleeding 
immediately” (Lin, C., [20]). Although that particular doctor worked at a Chinese hospital, many 
health care workers around the world potentially have the misfortune to be put in the same 
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situation. Ambulance workers deal with emergencies quite often, so the risk of exposure that 
comes with immediately responding to an emergency is ever present. 
The majority of the studies conducted on health care workers and occupational exposure 
have involved the three bloodborne pathogens that pose the greatest risk: Hepatitis B, Hepatitis 
C, and Human Immunodeficiency Virus (HIV). Although exposure to these contaminants can 
happen through any of the several methods listed previously, the majority of instances of 
occupational exposure to bloodborne pathogens are through “percutaneous injury with a sharp 
object”, such as a needle or a lancet (Rapiti, E., [21]). 
 
Figure 9 – Reported Incidents of Percutaneous Injury with a Contaminated Sharp Object 
In a document produced by the World Health Organization (WHO), studies were conducted 
to evaluate the toll of HBV, HCV, and HIV on a global level. Part of this evaluation involved 
using data from countries within the 14 WHO regions as listed in Figure 9. This figure details the 
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number of health care workers who become exposed to one or more percutaneous injury with a 
sharp object (Rapiti, E., [21]). 
 
Figure 10 – Percentages of Infections among Healthcare Workers 
In the same WHO document, they had modeled and provided an estimate of the percentage 
of infections in health care workers by HBV, HCV, and HIV. One point in Figure 10 that might 
be of interest is Amr A, the region in which the United States is classified (Rapiti, E., [21]).  
Other pieces of literature that deal with the same subject have produced similar results, with 
only some variation, partially due to the fact that the risk is dependent on whether the 
contamination is “e” antigen positive or negative. For HBV, the risk of acquiring HBV from 
percutaneous injury has been listed as ranging from 6 to 30% (Marino, C. G. G., [18]) or even as 
high as 40% (Varghese, G. M., [22]). In the case of HCV, the risk is a bit lower, being listed as 
between 3 and 10% (Marino, C. G. G., [18]), 0 and 7% (Varghese, G. M., [22]) or 1.2 and 10% 
(Sadoh, W. E., [23]). For HIV, the risk seems to be more consistent between literature sources, 
described as being 0.3% through percutaneous injury, or 0.09% after mucous membrane 
exposure (Marino, C. G. G., and Vargese, G. M., [18, 22]). 
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Table 5  - Post-exposure HIV Infection Risk 
 Adjusted Odds Ratio 
Deep Injury 16.1
Visible Blood on Device 5.2
Procedure Involved Needle Placed Directly in Blood or Artery 5.1
Terminal Illness in Source Patient 6.4
Postexposure use of Zidovudine 0.2
 
One literature source investigated other factors that might affect the risk of HIV infection in 
health care workers exposed to infected blood, discussing factors such as deep injury to the 
health care worker, terminal illness in the patient, or post-exposure use of zidovudine, a type of 
antiretroviral drug. As can be seen in the Table 5, deep injury has great effect on the risk of 
becoming infected with HIV (Johnson, D. C., [24]).  
Although airborne pathogens do not present as great a risk in occupational exposure, there is 
still some literature to suggest that precautions should still be taken. One article, describing the 
prevalence of H1N1 among hospital staff at a hospital in Singapore listed that among 531 
participants in the study, 35 showed evidence of seroconversion, most of whom were nurses 
“posted to designated pandemic (H1N1) 2009 isolation wards” (Chen, M., [25]). This result 
suggests that any health care worker who spends a significant amount of time around an infected 
individual runs a higher risk of contracting the disease themselves. If proper precautionary 
measures are not taken, as in low to middle income nations, risk of contracting airborne 
pathogens may be significant, as mentioned in another article detailing the incidence and 
prevalence of latent tuberculosis infection (LTBI) among health care workers. By collecting data 
from nations such as India, Mexico, Thailand, South Africa, and others, it was demonstrated that 
estimates of the annual risk of contracting LTBI ranged from 0.5 to 14.3% (Joshi, R., [26]). 
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2.5 Cleaning Agents 
In addition to emphasizing the importance of consistent and effective cleaning in 
disinfecting procedures, the United States Environmental Protection Agency has categorized 
antimicrobial agents for cleaning different types of contamination (Environment Protection 
Agency, [27]).  With a wide selection on the market, cleaning agents differ greatly in their cost 
and intended use.  Antiseptics and disinfectants are used extensively in health care settings for a 
variety of applications.  In hospitals, they are used mainly for preventing disease transmission 
and aiding infection control.  The general recommendation for cleaning under any health care 
related setting is that cleaning should occur from the cleanest area to the dirtiest (McDonnel, G., 
and Russell, A., [28]).  In the general public, the recent growing attention to disinfection has led 
to increased use of antiseptics and disinfectants in household cleaning products.  A wide variety 
of active chemical agents, also called biocides, can be found in these popular products.  A 
biocide is a term describing a chemical agent of any nature that inactivates microorganisms.  
Ranging in antimicrobial activity, biocides differ in the way they kill germs.  Unfortunately, the 
recent widespread use of antiseptic and disinfectant products has raised serious speculation on 
the development of microbial resistance, especially cross-resistance to antibiotics (McDonnel, 
G., and Russell, A., [28]).  Therefore, it is crucial for healthcare workers to choose the correct 
cleaning agents for both maximum effectiveness and minimum microbial resistance. 
Under healthcare settings, contamination is commonly defined as the soiling or pollution of 
inanimate or living material with harmful and potentially infectious substances.  These 
contaminations may be transferred to a susceptible target if not decontaminated properly and 
timely.  Decontamination is defined as a series of processes that removes or inactivates 
contamination, preventing sufficient quantities of microorganisms or other harmful substances 
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from spreading.  The process of decontamination is composed of a number of steps, including 
cleaning, disinfection, and/or sterilization.  The series of decontamination procedures allow for 
safe usage of reusable medical equipment and instruments.  As the first level of decontamination, 
cleaning is the process of removing any visible contamination from surfaces.  It must be 
conducted before disinfection and sterilization.  For certain low-risk items, cleaning may be all 
that is required before they are deemed reusable.  Usually achieved through the use of chemicals 
such as disinfectants, disinfection is the second step of decontamination that reduces the number 
of viable microorganisms, but it is not entirely effective against bacterial spores or some viruses.  
Disinfection is generally sufficient for medium-risk items, which do not come into contact with a 
break in the skin or mucous membranes.  Sterilization is a decontamination process in which all 
microorganisms, including spores and viruses are destroyed.  Most often achieved by high 
pressure and temperature steam, sterilization is much more time consuming, costly, and 
impractical when compared to disinfection. Thus, it is only used for high-risk items (United 
Kingdom National Health Service, [29]). 
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Table 6 - Recommended Disinfectants 
Disinfectants 
Type Example Comments 
Chlorine Dioxide Tristel Endoscope disinfection 
Sodium Hypochlorite Titan Sanitiser Spillages of blood/body 
substances – 
wards/departments 
Alcohol 70% Hand gel For use on physically clean 
hands – refer to hand hygiene 
guidelines 
Alcohol solution Skin preparation – not to be 
used for soaking items of 
equipment 
Cliniwipes/mediwipes 
Mediswabs 
Skin preparation wipes may be 
used for smooth, clean 
surfaces or 
equipment that cannot be 
immersed in solutions 
Chlorhexidine Hibitaine Skin preparation/surgical 
scrub 
Not necessary for routine hand 
washing – liquid soap 
adequate 
Iodine Betadine 
Disadine 
Videne 
Skin preparation 
Hand disinfection 
 
A number of disinfectants and antiseptics that are recommended for disinfecting surfaces 
and skin are listed in Table 6.  Chlorine dioxide, commonly found in Tristel, is highly effective 
for the disinfection of various types of endoscopes.  Sodium hypochlorite found in Titan 
sanitizer, is great for neutralizing spillages of blood and other body substances and fluids.  70% 
alcohol is widely used in hand gels, alcohol wipes and swabs, is effective for disinfecting 
cleaned surfaces or equipment that cannot be soaked in solutions.  It is also useful in skin 
preparation.  To ensure effectiveness, alcohol should always be allowed to evaporate from 
disinfecting surfaces before further usage.  Other antiseptics effective in the disinfection of skin 
include c
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doses of rhinovirus.  The subjects were randomly distributed into six hand treatment groups.  A 
control group received no treatment.  A second group washed their hands under running water 
for 15 seconds.  Another group washed their hands with non-medicated liquid soap and water for 
15 seconds.  A fourth group received 1.5 milliliter of 65% ethanol hand sanitizer to apply on the 
hands.  A fifth group received 3 milliliter of 65% ethanol hand sanitizer for two adjacent 
applications.  The final group applied 3 milliliter of 83% ethanol hand sanitizer in one 
application.  After the various hand treatments, all volunteers had their fingertips screened for 
residual virus.  As shown in Table 7, all ethanol treatments were significantly more effective 
than no treatment, water alone, or soap and water for removing rhinovirus from the hands.  As 
demonstrated in Figure 11, water alone only removed detectable virus from 13% of the 16 hands, 
while water and soap removed 31% from the individuals (Turner, R. B., et al., [30]).  The study 
also showed that no visible cleaning improvements can be observed from using more volume or 
more concentrated ethanol hand sanitizers. 
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other organic acid treated group waited 4 hours before similar exposure.  After allowing the virus 
to dry on the hands for 10 minutes, the fingers of the volunteers were screened for viable 
rhinovirus.  As shown in Table 8 and Figure 12, the organic acid hand treatment had residual 
activity that inactivated the virus on the hands 2 and 4 hours after application.  The study 
demonstrated the importance of using appropriate disinfectant and antiseptics, especially for 
emergency responders that frequently come in contact with pathogenic contaminants (Turner, R. 
B., et al., [30]).  Not only can ethanol hand sanitizers effectively remove viruses from the hands, 
ethanol-based sanitizers containing formulated organic acids are also capable of significantly 
reducing virus recovery from the hands for up to 4 hours after application. 
 
2.5.1 Current Ambulance Cleaning Methods 
As vehicles used for providing emergency medical care, ambulances carry patients with 
various kinds of diseases and illnesses.  In order to prevent cross contamination and infection 
within an ambulance setting, staff have a responsibility to keep the vehicle clean.  Otherwise, 
those same vehicles can become a haven for pathogens.  Research has shown that ambulances 
are potentially the weakest link in the fight against diseases such as MRSA and other superbugs.  
This is partly because ambulance crews do not always have the time to thoroughly clean and 
disinfect the interior of the vehicles between emergency calls (BBC News, [31]). 
In order to keep ambulances clean and to reduce improper cleaning techniques, the U.S. 
Department of Health & Human Services proposed a series of guidelines for cleaning EMS 
transport vehicles.  The published governmental guidance recommends that EMS agencies 
consistently practice basic infection control procedures, and properly use Food and Drug 
Administration-regulated medical personal protective equipment.  The guidelines also stressed 
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the importance of extra precaution during influenza seasons (United States Department of Health 
and Human Services, [32]).   
The basic components of effective contaminant control include routine cleaning of the 
patient loading area with soap or mixture of detergent and water to remove soil and organic 
matter, followed by the use of disinfectants.  To ensure reusability of ambulance equipment, 
equipment should be covered with disposable covers to protect them from contamination if they 
cannot be properly decontaminated with disinfectant without causing damage to the hardware.  
The covers should be routinely changed or whenever visibly contaminated.  The routine cleaning 
method should be implemented throughout the interior of the ambulance, especially in certain 
hard-to-clean areas as listed below (BBC News, Unites States Department of Health and Human 
Services, [31, 32]): 
1. EMS agencies should clean and disinfect non-patient-care areas of an ambulance such as 
the driver’s compartment according to the vehicle manufacturer’s recommendations.  
These areas of the vehicle may become unintentionally contaminated by the ambulance 
staff touching the steering wheel with a contaminated glove. 
2. Ambulance staff should wear non-sterile, disposable gloves that are compatible with the 
types of detergent and disinfectant used while handling the cleaning solutions and when 
cleaning the ambulance surfaces.  Used gloves should be disposed in a sturdy leak-proof 
bag if they become damaged, soiled, or after cleaning is complete.  Used gloves should 
never be washed or reused.  All personnel should avoid activities that may generate 
infectious aerosols while cleaning the interior of an ambulance, and the staff should wear 
eye protection such as a face shield or goggles if splashing is expected. 
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3. Frequently contaminated surfaces in patient-care compartments are identified including 
stretchers, railings, medical equipment control panels, adjacent flooring, walls, ceilings, 
work surfaces, door handles, radios, keyboards, and cell phones.  These surfaces can be 
directly contaminated with respiratory secretions, aerosols, and other bodily fluids during 
patient care, or indirectly contaminated by touching the surfaces with gloved hands.  
Periodically, these areas should be cleaned with detergent and water, and then disinfected 
using an EPA-registered hospital disinfectant according to its instructions.  It should be 
noted that some manufacturers recommend cleaning their electronics only by wiping the 
housing with a soft cloth dampened with a mild detergent and water to avoid disinfecting 
or cleaning solutions oxidizing the circuitry through corrosion. 
4. For non-porous surfaces in patient-care compartments that are not frequently touched, 
detergent and water are sufficient for cleaning the surfaces.  Cleaning methods that can 
potentially produce aerosols or mists should be avoided in the patient-care areas. 
5. For small spills of bodily fluids, clean with detergent and water, and then disinfect using 
a hospital disinfectant in accordance with the manufacturer’s instructions.  Large spills of 
bodily fluids should be cleaned by removing any visible organic matter with absorbent 
material, then cleaned and disinfected using the same procedures. 
6. Contaminated reusable patient care devices and equipment should be placed in biohazard 
bags labeled for cleaning.  The devices and equipment should be disinfected or sterilized 
according to the manufacturer’s instructions. 
7. After cleaning, properly dispose used gloves then clean hands with soap and water or an 
alcohol-based hand gel.  The ambulance staff should avoid touching the face with gloved 
or unwashed hands. 
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should take extra precaution avoid contacting bare skin with the outside surface of used gloves 
(Patwardhan, N., [33]).  
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CHAPTER 3. EMS CONTAMINANT ISOLATION ENGINEERING 
3. Introduction 
Medical ambulances are used all over the world during both rescue operations and 
transportation of the sick or injured.  The primary purpose of an emergency medical ambulance 
is to provide pre-hospital care to patients with illnesses or injuries and transport them (Pollak, N. 
A., [3]).  In areas of high ambulance usage quick turnover time is critical.  The working 
environment inside of an ambulance must be clean and free of any contaminants such as 
bloodborne pathogens, airborne pathogens, and harmful gases. 
Firstly, as mentioned before, turnover time for ambulances are critical especially for areas of 
high incident rates and/or limited number of ambulances.  However, at the same time it is 
important to ensure that the ambulance is free of potential pathogens.  Current ambulance 
decontamination methods can potentially use chemicals that pose a health threat to the workers 
and take time due to the manual labor.  The revision of the decontamination procedures will 
entail the enhancement of current methods, chemicals, and if time permits, the proposal of a new 
interior design for ambulances. 
Secondly, pathogens and hazardous material can be commonly found in our everyday lives.  
For example, a passenger on a bus coughing may merely have the common cold, or could 
potentially have the Influenza or even Tuberculosis.  It is hard to definitively identify such 
threats and therefore universal precautions must be employed.  However, to enforce such 
precautionary measures is also near to impossible.  The revision of the current precautionary 
measures will merely entail comparing and modifying current devices that exist to make the 
ambulance a safer environment. 
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Thirdly, there are many biosensors and hazardous gas detectors that have been developed for 
various reasons.  Some detectors are small and reliable enough that may be a viable candidate for 
use in the pre-hospital care environment.  The identification of efficient, effective and reliable 
pathogen detection systems will entail research and proposal of currently available sensors and 
even sensors in the research and development phase. 
Lastly, the project includes research and proposals of potential areas of enhancement for a 
more friendly emergency medical service.  A summary of the project was presented to the team 
and our advisor, and can be found in Appendix J. 
 
3.1 Worcester Emergency Medical Service Visit 
Part of the background research that was needed for this project involved speaking with 
actual paramedics and discussing their first-hand experiences with working in the ambulances. 
One evening, our group had the opportunity to speak with a few paramedics from the University 
of Massachusetts Memorial Hospital and to observe the ambulances in which they work. Some 
of the questions that we had prepared before the meeting included, but were not limited to: 
1.     Do you clean KEDs, Splints, and traction devices after they are used? And if so how 
often?  
2.     What else do you clean? 
3.     Is there equipment that does not get cleaned after each run? 
4.     How often are stretcher mattresses cleaned? 
5.     What cleaning solutions do you use? 
6.     What protective equipment is required for the cleaning material being used? 
7.     How long does it take to clean? 
42	
	
8.     Are there any instances where you have to be dispatched even when you are still 
cleaning? 
9.     What are some last minute actions you take when dispatched during cleaning? 
10.     Would you feel comfortable learning and using new cleaning procedures, given the 
new procedures are more effective? 
Through our discussion with the paramedics, we were able to gain more of an insight into 
their environment. We learned about some of the major areas of concern for contamination, such 
as the creases between cushions: a difficult area that might collect blood due to the fact that the 
cushions are not removable. Also, the paramedics mentioned that various handles or railings for 
support could be a potential area for contamination, since they are constantly being touched by 
gloved hands which may have bodily substances on them. And because soiled gloves may not be 
replaced during patient care, radios and control panels may also be at risk for contamination. In 
fact, one of the main complaints the paramedics had were that the switches of the control panel 
had very small spaces in between them, making them nearly impossible to fully clean. 
Many devices in the ambulance such as KEDs or short boards are constructed from 
materials that do not absorb contaminants such as blood, and therefore can be cleaned through 
scrubbing and disinfecting with germicidal wipes. Items that might absorb bodily fluids such as 
straps can be removed and washed, but if they become soiled to a great degree, they are disposed 
of and replaced. 
For the actual cleaning process, we were told that it is usually up to the paramedic to clean 
the ambulance at the end of his/her shift, although some opt to clean the ambulance after each 
call. The thoroughness of the clean is also at the discretion of the paramedic. The individual we 
talked to regarding this subject mentioned that he typically likes to use a power washer using a 
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hose at the hospital to spray down areas of the ambulance. The cleaning process varies with the 
amount of contamination present in the ambulance, and can range between five and fifteen 
minutes in duration. The paramedic we spoke to mentioned that when cleaning the ambulance, 
he typically wears gloves, but no other form of PPE. However, should another call come in 
before the ambulance is fully cleaned, it is likely that only the major areas will end up being 
sanitized.  
Some final things that we noted from our meeting with the paramedics were that they 
typically use bleach to clean the ambulance, which was among the cleansing agents that we had 
researched. In addition, one interesting thing we were told was that there was no drainage system 
in the ambulance and that any blood or bodily fluid that might spill onto the floor would just 
migrate around the floor of the ambulance as the ambulance moved, usually collecting at the 
bottom of some steps leading from the ambulance side door. 
 
 
3.2 Ultraviolet Germicidal Irradiation  
One of the first technologies we considered incorporating in the ambulance system was 
Ultraviolet Germicidal Irradiation (UVGI). This technology involves emitting light at a certain 
wavelength to kill pathogens exposed to it, in the air or on surfaces. Generally, it is hoped that 
such a device would be able to cut down on the amount of time needed to disinfect an ambulance 
between runs, and to cut down on the amount of labor needed to be done by the healthcare 
worker responsible for cleaning the ambulance. Also, it is desirable to have a device that is 
capable of disinfecting areas of the ambulance that might be difficult to reach through manual 
cleaning. In the healthcare industry, UVGI has mainly seen testing in hospitals, such as in patient 
rooms where hospitalized patients had been infected with pathogens such as MRSA. Without 
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For the most part, many applications of UVGI involve either surface decontamination, upper 
room irradiation, or duct irradiance. 
Surface decontamination involves using UV lamps in an area where it is well-positioned so 
that the UV-C light is in direct line of sight of as many contaminated surfaces as possible. 
Several studies have been conducted on a device called the TRU-D (Total Room Ultraviolet 
Disinfector), developed by the Lumalier corporation. The TRU-D is stated to be able to measure 
“UV-C intensities reflected from the walls, ceilings, floors, or other treated areas” so that it can 
be able to calculate the correct dose needed to eliminate pathogens (Owens, M. U., et al., [41]). 
One study conducted to evaluate the usefulness of such a UVGI device found that in a test room 
with vegetative bacteria and C. difficile spores prepared on formica sheets, a 99.9% reduction of 
the vegetative bacteria was achieved in 15 minutes, while a 99.8% reduction in spores was 
achieved in 50 minutes. This study also looked at the effectiveness of surface decontamination in 
actual patient rooms where patients had been placed under “contact precautions to prevent 
transmission of MRSE or VRE” (Rutala, W. A., et al., [34]). 
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Figure 17 – Effects of UVC Light on CFUs 
 
As Figure 17 shows, significant reduction of contamination was achieved after UV-C light 
had been applied. This data was obtained with a mean UV exposure time of only approximately 
17 minutes. The study also mentioned that this particular surface decontamination device using 
UVGI was effective in reducing contaminants in both direct and indirect exposure of UV-C light 
(Rutala, W. A., et al., [34]). 
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Figure 18 – Effects of UVC Light on CFUs of Pathogens of Concern 
 
Another study performed a similar experiment using the TRU-D device in hospital rooms 
where patients had been on contact precautions for MRSA or C. difficile, and had not been 
cleaned by hospital staff yet. In the study, a total of 261 surfaces from 66 rooms were cultured to 
quantify the mean number of colony-forming units (CFU) per square centimater for each type of 
contaminant, both before and after application of UV-C light. As can be seen from Figure 18, 
UVGI caused a significant amount of reduction (Nerandzic, M. M., et al., [39]). 
In the practice of upper room irradiation to remove contamination, UV lamp fixtures are 
suspended from the ceiling and/or installed onto the walls. They are set up so that all the 
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radiation is directed upwards, so that the occupants below are not exposed. This creates an 
“intense zone of UVGI” in the upper levels of the room, effectively killing airborne pathogens 
that enter. This sytem requires, however, some air mixing to ensure that microorganisms in the 
lower levels of the room eventually reach the UVGI zone (Center for Disease Control and 
Prevention, [42]). 
 
Figure 19 – Effects of Upper Room UVGI and Air Ionizers in Preventing TB Infection 
 
In a study conducted in Lima, Peru inside a HIV-TB ward in a hospital, three groups of 
guinea pigs were exposed to ward air in order to test the effectiveness of UV lights and negative 
air ionization. As can be seen from the recreated table results in Figure 19, UV lights 
demonstrated the highest likelihood prevention for developing tuberculosis infection or disease. 
As the study’s analysis using an airborne infection model stated, “ionizers prevented 60% of TB 
infection and 51% of TB disease, and that UV lights prevented 70% of TB infection and 54% of 
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TB disease.” Based on this analysis, they concluded that “UV lights tended to be more protective 
than ionizers” (Escombe, A. R., [43]). A number of other studies come to a similar conclusion 
that upper room irradiation provides “useful air disinfection” (Brickner, P. W., [36]). 
Due to the fact that ambulances do not have large air ducts, the concept of duct irradiation as 
a means of providing UVGI has not been explored in-depth for this project. It is still worthwhile, 
however, to give it a brief mention. For this form of UVGI, UV lamps are placed inside air ducts 
to disinfect exhaust air before it circulates back into the room. In duct irradiation, it is important 
that the flow rate of air through the ducts is not too high, due to the fact that each pathogen has a 
specific residence time of UV-C exposure needed to become deactivated. Generally, UV lamps 
in air ducts are seen as a supplementary measure to HEPA filters, and not as a replacement 
(Center for Disease Control and Prevention, [42]).  
 
3.2.2 Product Details 
In order to perform some analysis on the existing pieces of UVGI technology currently on 
the market, several pieces of equipment of varying designs and purposes were selected and 
analyzed. This analysis included investigating properties such as time needed to reduce 99% of 
select pathogens, initial costs, operation costs, and size (refer to appendix D for exact product 
specifications and images). The products researched mainly came from two companies: Lumalier 
Corporation, and American Air and Water, Inc. All of these products were studied to see how 
each would fare if implemented into the ambulance setting. Although some products did not list 
all of the information we desired for complete analysis, through similarities of products between 
the two aforementioned companies, we were able to at least gain a vague idea of the properties 
possessed by each device type. From American Air and Water, Inc, the devices we looked into 
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included: the AAW Handheld Ultraviolet Germicidal System (a handheld device), the AAW-
TBE-14-1 In-Room Ultraviolet Germicidal System (an air purifier), and the MRS3684P Mobile 
Room Sterilizer (a mobile room sterilizer). From Lumalier Corporation, the devices we looked 
into included: the BLU236 and BLU436 (a series of ceiling mounted disinfectors), the ADU (a 
ceiling mounted disinfector specifically designed for ambulances), and TRU-D (a mobile room 
sterilizer). Product specifications from the websites of Lumalier and American Air and Water 
can be seen in Appendix D. 
Part of the analysis needed to evaluate each product was to understand the intensity of the 
UV-C light that each device produced. Some products, such as the ones from American Air and 
Water listed the intensity of the light sources. Some products from Lumalier Corporation, 
however, only listed UV-C watts. Still, we were able to notice from a table provided by 
American Air and Water for replacement UV lamps that the UV Intensity at one meter was 
approximately equal to the UV output multiplied by 10.8. 
 
Table 9 – UV Lamps Table from American Air and Water, Inc 
Length Lamp Model Lamp Description UV Output (W) Lamp Intensity (µW/cm² @1 m) 
6’’ GML170 Hot Cathode Lamp 0.5 5.4 
12’’ GML125 Slimline Lamp 6.0 66 
16’’ GML430 High Output Lamp 10.0 108 
24’’ GML435 High Output Lamp 16.2 175 
 
The abridged table, Table 9, details the UV output and UV intensity for each lamp model 
sold by American Air and Water. The table in its entirety can be seen in Appendix B. Although it 
is not exact, it can be seen how the UV output in W (watts) multiplied by 10.8 is approximately 
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equal to the UV intensity in µW/cm² at one meter from the surface (American Air & Water, Inc., 
[44]). 
Table 10 – UV Dosage Table 
Organisms: Energy Dosage of Ultraviolet radiation (UV 
dose) in µWs/cm2 needed for kill factor 
Bacteria 90% (1 log reduction) 
99% 
(2 log reduction) 
Bacillus anthracis - Anthrax 4,520 8,700 
Bacillus anthracis spores - Anthrax spores 24,320 46,200 
Clostridium tetani 13,000 22,000 
Corynebacterium diphtheriae 3,370 6,510 
Ebertelia typhosa 2,140 4,100 
Escherichia coli 3,000 6,600 
Mycobacterium tuberculosis 6,200 10,000 
Salmonella typhosa - Typhoid fever 2,150 4,100 
Shigella dyseteriae - Dysentery 2,200 4,200 
Staphylococcus aureus 2,600 6,600 
Vibrio comma - Cholera 3,375 6,500 
Molds 90% 99% 
Aspergillius flavus 132,000 330,000 
Virus 90% 99% 
Infectious Hepatitis 5,800 8,000 
Influenza 3,400 6,600 
Poliovirus - Poliomyelitis 3,150 6,600 
 
Also from American Air and Water, Table 10 was made for many microorganisms, detailing 
the energy dosage of ultraviolet radiation need to achieve a 90% or 99% reduction. For each of 
the products, the UV intensity was listed, in some cases needing to be calculated first from UV 
output (American Air & Water, Inc., [45]).  
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Table 11 – Product Specification Table 
Product Name Nominal Watts (W) UV-C Watts (W) UV Intensity 
(µW/cm² @1 m) 
AAW Handheld Ultraviolet 
Germicidal System  
4.7 
 
1.6 17.1 
AAW-TBE-14-1 In-Room 
Ultraviolet Germicidal System 
14.2 4.7 51.1 
MRS3684P Mobile Room 
Sterilizer 
264 88 880 
BLU236 72 24 240 
BLU436 144 48 480 
ADU 36 12 120 
TRU-D (Total Room 
Ultraviolet Disinfector) 
Unavailable Unavailable Unavailable 
 
Table 11 lists the UVGI products listed before. The cells in italics indicate a calculated 
estimate. The product specifications found for the Lumalier devices only listed the nominal 
watts, and the UV-C watts. Thus, the UV intensity for the Lumalier products was approximated 
by multiplying the UV-C watts by 10.8, due to the observation that the ratio of UV intensity 
from 1 meter to UV-C watts was equal to 10.8. The product specifications for the American Air 
and Water, Inc. only listed the UV intensity, so UV-C watts was approximated by dividing by 
10.8. As for the nominal watts, it was observed that UV-C watts was equal to one third of the 
listed nominal watts in Lumalier products. Therefore, the calculated UV-C watts was multiplied 
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by three to find the approximate value for nominal watts. However, the UV intensities provided 
by the product details were expressed at a distance of six inches for the handheld device and one 
foot for the air purifier. In the interests of keeping the UV-intensities consistent for all products, 
they were converted to find the UV intensity at a distance of one meter, similar to the provided 
table for the UV lamps. In order to convert the UV intensities, the Inverse-Square Law was used. 
ܫଵ
ܫଶ ൌ ൬
݀ଶ
݀ଵ൰
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When this equation was used, I1 was the UV intensity provided by American Air and Water, and 
d1 was the distance (converted to meters) for the provided UV intensity. I2 was the UV intensity 
that we tried to solve for, and d2 was equal to one meter.  
For the TRU-D, and the similar product from American Air and Water, the MRS3684P, 
neither wattage nor UV intensity was listed in the product specifications. For the MRS3684, 
however, it was mentioned that the product utilized eight GML100 lamps, which each possess a 
UV intensity of 110 µW/cm² at one meter. In order to approximate the total UV intensity of the 
device, we chose to multiply 110 µW/cm² by eight. This is an approximation – it is very likely 
that since each lamp is not the same distance away from a particular surface, it is an 
overestimate. Although the MRS3684 and the TRU-D have similar functions, and even look 
vaguely alike, we felt that we could not estimate the properties of the TRU-D from the properties 
of the MRS3684 due to the fact that the TRU-D used a different number of lamps of unknown 
UV intensity. 
With the UV intensities calculated for most of the products researched from Lumalier and 
American Air and Water, it was then possible to calculate the time needed to achieve a 90% of 
99% reduction of various pathogens. The time needed to achieve a desired reduction of a 
particular microorganism was calculated by the following equation. 
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The UV Energy Dosage mentioned in the equation refers to the dosages listed in Table 10. 
The UV Intensities refer to the ones calculated earlier in Table 11. It must be remembered that 
since each UV Intensity was calculated at a distance of one meter, the following calculated times 
assume a distance of one meter between the UV-C light source and the surface. 
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Table 12 – UVGI Device Reduction Times for Major Contaminants 
Organisms UV Dose Needed 
Time Required for Reduction (seconds) 
Bacteria 
99% 
(2 log 
reduction) 
AAW 
Handheld
AAW-TBE-14-1 
In-Room 
MRS3684P BLU236 BLU436 ADU 
Bacillus 
anthracis - 
Anthrax 
8,700 
508.77 170.25 9.89 33.56 16.78 67.13 
Bacillus 
anthracis spores 
- Anthrax spores 
46,200 
2701.75 904.11 52.50 178.24 89.12 356.48 
Clostridium 
tetani 22,000 
1286.55 430.53 25.00 84.44 42.44 169.75 
Corynebacterium 
diphtheriae 6,510 
380.70 127.40 7.40 25.12 12.56 50.23 
Ebertelia 
typhosa 4,100 
239.77 80.23 4.66 15.82 7.91 31.64 
Escherichia coli 6,600 385.96 129.16 7.50 25.46 12.73 50.93 
Mycobacterium 
tuberculosis 10,000 
584.80 195.69 11.36 38.58 19.29 77.16 
Salmonella 
typhosa - 
Typhoid fever 
4,100 
239.77 80.23 4.66 15.82 7.91 31.64 
Shigella 
dyseteriae - 
Dysentery 
4,200 
245.61 82.19 4.77 16.20 8.10 32.41 
Staphylococcus 
aureus 6,600 
385.96 129.16 7.50 25.46 12.73 50.93 
Vibrio comma - 
Cholera 6,500 
380.12 127.20 7.39 25.08 12.54 50.15 
Molds 99%       
Aspergillius 
flavus 330,000 
19298.25 6457.95 375.00 1273.16 636.58 2546.33
Virus 99%       
Infectious 
Hepatitis 8,000 
467.84 156.56 9.09 30.86 15.43 61.73 
Influenza 6,600 385.96 129.16 7.50 25.46 12.73 50.93 
Poliovirus - 
Poliomyelitis 6,600 
385.96 129.16 7.50 25.46 12.73 50.93 
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Table 12 details the amount of time needed to reduce various contaminants. Although the 
UV Energy Dosage for many microorganisms were provided (as can be seen in Appendix C), the 
reduction time was only calculated for the select contaminants above. For the devices that have a 
relatively high UV intensity (>100 µW/cm² @1 m), most bacterial species and viruses can be 
reduced by 99% in close to a minute or under. Molds and bacterial spores, however, take quite a 
bit longer. Even devices that have a lower UV intensity (<100 µW/cm² @1 m) can eliminate 
most of the contaminants in the above table in only a few minutes.  
Another property of interest for each of the UGVI products discussed thus far is cost. 
Certain products may cost more than others, or may consume more power, which means higher 
operation costs. One equation that we found described the operating cost of a device that runs off 
of power from an outlet (Kowalski, W. J., [38]). 
ܱ݌݁ݎܽݐ݅݊݃	ܥ݋ݏݐ	ሺ$ሻ ൌ 	ܲ ൈ ܪ1000 ൈ ௖ܲ 
For this equation, P was equal to the total watts of power consumed by a lamp fixture. H 
was equal to the total number of hours in a year for which the device would be in use. Pc 
represented the power charge, which we approximated as being 0.1 $/kWh. In order to calculate 
the operating cost, we used the nominal watts listed in Table 11 as the total watts of power 
consumed, P. For H, we assumed a value of 750 hours, or a little over 2 hours of use a day. 
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Table 13 – Operating and Initial Costs 
Product Name Nominal Watts (W) Operating Cost ($) Selling Price ($) 
AAW Handheld 
Ultraviolet 
Germicidal System 
4.7 0.35 400.00 
AAW-TBE-14-1 In-
Room Ultraviolet 
Germicidal System 
14.2 1.07 499.00 
MRS3684P Mobile 
Room Sterilizer 
244.4 18.33 7399.00 
BLU236 72 5.40 Unavailable 
BLU436 144 10.80 Unavailable 
ADU 36 2.70 Unavailable 
TRU-D (Total Room 
Ultraviolet 
Disinfector) 
Unavailable Unavailable Unavailable 
 
In Table 13, the equation for operating cost was evaluated for each device, based off of its 
nominal watts value. In addition, the table displays the selling price for some of the devices, as 
stated by the company. Although we were able to find prices for products from American Air 
and Water, at the time of writing for this project, we have been unable to ascertain selling prices 
for products from Lumalier. As the table shows, the yearly operating cost of using devices, 
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assuming they can be plugged into an outlet, is quite low. It would seem that a large part of the 
cost that comes from using a UVGI device would be the initial cost from purchasing one. 
Another property of interest to investigate the viability of using these UVGI devices in the 
ambulance was size. In the ambulance setting, there is a limited amount of space. A large amount 
of the volume of the ambulance’s interior is used for both equipment and space for the patient 
and paramedic. An investigation into the space needed for each device is necessary to determine 
whether it should be a permanent, removable, or whether it should even be used at all. 
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Table 14 – Physical Dimensions 
Product Name Length (in) Width (in) Height (in) Volume (in3) 
AAW Handheld 
Ultraviolet 
Germicidal 
System 
18 
 
5 6.25 562.5 
AAW-TBE-14-1 
In-Room 
Ultraviolet 
Germicidal 
System 
20 5 4 400 
MRS3684P 
Mobile Room 
Sterilizer 
20 20 48 19200 
BLU236 18 8 4.5 648 
BLU436 36 8 4.5 1296 
ADU 18 5 3 270 
TRU-D (Total 
Room Ultraviolet 
Disinfector) 
Unavailable Unavailable Unavailable Unavailable 
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Using the available specifications for each of the UVGI devices from American Air and 
Water and Lumalier, the general physical dimensions and weights for the products were 
tabulated in Table 14. Not every specification was given for all products, however, and to try and 
estimate missing information by using general material compositions or comparisons to slightly 
similar products would still only result in little more than guesses. But from a general look at the 
data, it would seem the only item that could not be a permanent fixture within the ambulance is 
the MRS3684P Mobile Room Sterilizer, due to the fact that it is quite large. It may be possible to 
move it into the ambulance as needed, during periods of when the ambulance is not in use. The 
weight of the device is not known, however, and so it might be extremely difficult to lift and 
place in the ambulance. The BLU236, BLU246, and the ADU might be implementable as 
permanent fixtures within the ambulance since they are ceiling fixtures with a relatively low 
height, so as not to adversely affect head clearance. Although not much is known about ideal 
placement for the AAW-TBE-14-1 In-Room Ultraviolet Germicidal System, the fact that it 
probably does not need to be placed in the center of the ceiling like some of the other devices, 
and that it has a reasonable volume might indicate that it is also a candidate for being a 
permanent fixture. The AAW Handheld Ultraviolet Germicidal System is described as being a 
handheld device, so installing it as a permanent fixture within the ambulance might not be 
necessary. Its size does not preclude its use in the ambulance, however. 
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3.2.3 Analysis 
After doing research into the mechanism behind UVGI, the scientific literature evaluating 
its effectiveness, and the details of products currently in existence, we were able to arrive at a 
few conclusions regarding the viability of implementing such a technology in the ambulance 
setting.  
There are several positive aspects to using UVGI devices in the ambulance. As can be seen 
in an analysis of the scientific literature, it can be very effective at reducing a large percentage of 
microorganisms in a reasonable amount of time in the hospital setting. One of the major appeals 
to using such devices is that many of them are automated; meaning that little manual labor might 
be expected of paramedics responsible for decontaminating the ambulance. Also, many of the 
devices currently in existence are of a reasonable size and portable, meaning that there exists a 
possibility to implement such devices in the ambulance permanently. Even if space does not 
permit the usage of such devices in a permanent capacity, much of the ambulance cleaning takes 
place in a setting with appropriate cleaning tools, and so it might be assumed that UVGI devices 
could be kept at these locations to be added and removed as needed for the cleaning process. In 
addition, our analysis of some of the products on the market indicate that the cost of operating 
such devices using an outlet is relatively inexpensive, especially considering how the intermittent 
need for ambulance cleaning precludes the need for continuous running of the devices. In 
addition, bulbs are advertised at being capable of working up to 8000-12000 hours of continuous 
use (American Air & Water, Inc., [44]), and so it is very possible that ambulance crews could go 
a long time without the need to replace lamps. 
 There were some drawbacks that we discovered during our analysis, however. Although 
the operating cost of using UVGI devices were relatively inexpensive, the initial purchasing 
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costs of the devices might be too much for an emergency medical department’s budget. In 
addition, although it has been previously mentioned that UV-C light is effective at reducing 
contamination, it has been mentioned by some that the existence of dust or dirt can significantly 
inhibit the ability of radiation to eliminate microorganisms (Rutala, W. A., et al., [34]). 
Therefore, manual labor for cleaning the ambulance would still be needed, in order to remove all 
the dust and dirt. Finally, as mentioned before, UV-C light can be a safety concern. Human 
exposure to the radiation can result in sunburns, and painful inflammation of the cornea in the 
eye (Nardell, W. A., [46]). Remotely controlled devices should be used with caution, and care 
should be taken to ensure that automatic devices such as the TRU-D have properly working 
failsafes that terminate emission of UV-C light when movement is detected, such as the opening 
of a door (Nerandzic, M. M., et al., [39]). 
Some of the sources of error in this analysis might arise from the fact that the vast majority 
of the literature written on UVGI has taken place in the hospital setting. There might be 
unforeseen drawbacks to using a UVGI device in an ambulance versus a hospital room, and 
studies should be conducted to ensure efficacy. But due to the fact that UV dosage increases 
when surfaces are closer to the light source, and that ambulance patient care area is significantly 
smaller than a hospital room, it is very possible that the reduction time is lower in an ambulance 
than in a hospital. Some other sources of error that might arise from our analysis would be for 
our operating cost. We made a rough estimate of the operating cost by using an equation that 
assumed the devices were running of power from an outlet. It is very possible that some of the 
currently existing devices run on batteries, and thus the operating cost might be greater. Finally, 
our results are based off of an analysis of UVGI devices from only two companies, many of 
which provided products that served different functions from one another. For a more accurate, 
general p
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Figure 21 shows approximate particulate sizes of many different items, some of which are 
relevant to the ambulance setting. Measuring approximately 1-5 microns in diameter, typical 
mold and bacteria spores are well beyond the minimal filtration capability of 0.3 microns and can 
be easily trapped in the filter.  Under compact ambulance settings with minimal ventilation, 
transmission of any airborne diseases can be effectively terminated with the implementation of 
HEPA equipped air filtration systems. 
 
3.4 Biosensors 
The detection and identification of pathogenic bacteria and viruses are vital to the 
prevention of disease transmission in ambulance settings, in addition to proper treatment of 
infected EMT’s.  Although conventional methods are capable of accurately detecting biological 
substances, they usually involve time consuming procedures that take up to several days to yield 
results.  Therefore, a new method of pathogen detection is urgently needed, and the rising 
biosensor technology brings promise of near real time detection of pathogenic substances that is 
as sensitive and reliable as conventional methods.  A pathogen biosensor is defined as an 
analytical device that converts a biological response to an electric or visual signal, which is used 
to detect and identify the presence and concentration of biological substances such as pathogenic 
bacteria and viruses.  Biosensors often utilize biological systems like enzymes, antigens, cDNA, 
and B cells as means of detection (Heo, J., et al., [48]).  Common examples are blood glucose 
meters and pregnancy tests, which incorporate corresponding antigens for detection of interested 
substances in blood and urine.   
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3.4.1 Background 
In order to function accurately and effectively, all biosensors must satisfy several 
requirements.  First, they should be highly accurate, sensitive, and show a low detection limit.  
Since most bacteria have very high proliferation rate, a small number of undetected pathogenic 
bacteria and viruses can pose a serious risk to patients.  In addition, a number of government 
agencies such as USDA require zero tolerance of certain strains of bacteria including E. coli and 
Salmonella.  Second, the biosensors should have a rapid analysis time, which allows for 
immediate countermeasures to be taken.  Third, the detection processes used by the biosensors 
should not be affected by unsteady surrounding environment such as pH or temperature.  The 
reduced need for a controlled environment minimizes the use of lab equipment for preparation 
and allows for on-site real time monitoring.  Fourth, the biosensors should be able to detect and 
identify different strains of bacteria simultaneously within a sample.  One method to achieve this 
goal is to use multiple arrays of different sensors showing specificity toward different cells.  
Lastly, all biosensors should be cheap, portable, and easy to use, which allows operation by 
semi-skilled users without prior knowledge of lab techniques and skills (Olivier, L., et al., [49]).   
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commercially available on the market, with numerous promising biosensors almost completing 
development. 
 
3.4.2 Product Details 
One of the focuses of our project is to evaluate current biosensors and determine the 
viability and feasibility of implementing them in ambulance settings.  A number of biosensors 
that are currently available on the market or are at the end of their development were evaluated 
based on their ability to detect pathogens from different types of transmission routes.  “Bio-lab 
on a microchip” invented by a Caltech graduate, Frederick Balagadde, promises rapid, 
simultaneous detection of bloodborne pathogens from up to 100 samples at a time.  Unlike 
traditional methods of bloodborne pathogen detection such as ELISAs, which lack the ability to 
detect multiple pathogens from different samples simultaneously, Bio-lab on a microchip is 
capable of performing multi-pathogen detection from a large sample pool in only 4 hours 
(Balagadde, F. K., [51]).   
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Table 15 – Price Quotes 
Component Quantity Price 
BEX JPL 12 Nozzle 6 $300 
Compressor 1 $350 
Pump 1 $275 
Pneumatic Filter 1 $100 
Fluid pressure filter regulator 1 $95 
Tubing 1 $150 
Assorted fittings and brackets 1 $200 
Air cylinder 1 $150 
12V Battery 1 $150 
 
Table 15 demonstrates that the components for a cleaning mechanism are not overly 
expensive. 
Configuration of the nozzles is also very important. The positioning of the nozzles will vary 
from one ambulance to the other because of the different interior designs of each vehicle. Since 
this self-cleaning spray assembly will operate on high pressures, a total of six nozzles would be 
optimum for the ambulance.  
The total cost of the Self-Cleaning Spray mechanism would be approximately $1800. 
Although this system has a high installation costs, the cost of maintenance would be substantially 
lower because of short operation times.  Furthermore, maintenance costs would entail the 
occasional purchase of refilling the compressed-air cylinder and disinfectant solution.    
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ambulance since it potentially can get rid of any bloodborne or airborne pathogens present inside 
the ambulance. The spray should be able to reach all the surfaces and kill any bacteria that might 
spread to patients through surface contact.  Also, airborne pathogens present inside the 
ambulance are removed due to the aerosolized disinfecting solution by air atomizing nozzles. 
For the self-cleaning mechanism, it was proposed that a drainage system also be 
implemented in the ambulance.  Current ambulances lack a proper drainage system and any fluid 
remains on the floor of the ambulance until cleaned. This contaminates the ambulance floor 
spreading germs and bacteria across surfaces even where there was no spillage.  The fluid 
usually collects in the step on the side door which drains onto the road.  
For the proposed drainage system, the floor would have small slots cut into it with a mesh 
covering it. This would only let fluid pass through and would prevent any other material from 
entering the drain. Depending on the size of the ambulance, anywhere from two to four small 
sections of the floor could be cut. These cuts would be connected together by aluminum piping 
which would all drain into a disposable container. 
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CHAPTER 4. CONCLUSION 
4. Introduction 
Significant advancements have been made in the field of Emergency Medical Service in the 
past, such as proper procedures for patient care, federal guidelines for ambulance design, and 
unified standards for pre-hospital emergency care.  However, due to the increasing number of 
ambulance dispatches in recent years, conventional cleaning protocols and personal protective 
equipment are no longer adequate or sufficient to protect emergency responders and transported 
patients from various types of infectious diseases.  Therefore, the major objectives for our 
Interactive Qualifying Project are to (1) research and recommend designs for better body 
substance isolation systems that could prevent the spread of pathogenic particles in an ambulance 
setting, and to (2) recommend new cleaning procedures with the use of alternative 
decontamination equipment that could dramatically reduce ambulance downtime between 
dispatches.  When evaluating the viability of the engineering solutions proposed by the team, a 
number of constraints emerged, such as the cost, and interior placement for the recommended 
equipment.  Without presenting major modifications to the interior layout of an ambulance, the 
team strived to achieve the project objectives with minimum cost of purchase, installation, and 
maintenance for the proposed isolation systems and decontamination equipment. 
The IQP team started off the project with an intensive background research in all possible 
contaminants that could be present in an ambulance setting. The two major groups included are 
the bloodborne pathogens and the airborne pathogens. The IQP team conducted a detailed 
research in the modes of transmission of these pathogens and the diseases that they can spread.  
We also investigated which chemical agents are recommended to clean the ambulance, and how 
to protect the ambulance workers and patients from becoming infected. This data obtained was 
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then used to look for any available products that would remove the specific contaminants from 
the inside of the ambulance. 
In order to enhance cleaning procedures for the ambulance, current cleaning methods were 
investigated. A visit was made to the Worcester Emergency Medical Services to learn of the 
methods and procedures they use for ambulance cleaning. It was established that the current 
cleaning procedures are time-consuming and can be improved since there are no standard 
procedures laid out. Project goals were then decided and a comprehensive study was conducted 
to find the cheapest and most effective method of ambulance decontamination that would 
dramatically reduce ambulance downtime.  
Four different products were researched: UVGIs, air filters, biosensors, and the self cleaning 
mechanism. For many of the products, their specifications were listed and their efficiency in 
removing the pathogens was calculated.  Data indicated that UVGIs have high efficiency in 
removing pathogens from both the surface and the air. The efficacy of UVGI for airborne 
pathogens might increase with the use of HEPA air filter, however no specific HEPA filtration 
products were found.   Lastly, it was concluded that although biosensors were a promising 
technology for effective measurement of pathogens, currently they are very expensive and more 
research needs to be conducted to be able to use in an ambulance setting.  
As far as the theoretical self cleaning mechanism is considered, it is a relatively cheap and 
very quick way to flood the insides of the ambulance with a disinfectant spray which would 
neutralize most airborne pathogens and clean out almost all surface contaminants. The major 
drawbacks of such a system were its energy consumption and its ability to leave residue after its 
use. If the self-cleaning mechanism is used with the air filtration system, the issue might be 
resolved, yet the power issue might have to be solved with an additional battery.  
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As a whole, the recommendations provided by the IQP team are believed to provide 
significant improvements to what is currently available. Integrating the products studied in the 
project would possibly be an effective method to decontaminate the inside of an ambulance. 
Since such devices are relatively fast, it would potentially reduce ambulance downtime between 
dispatches, therefore meeting both goals of our project. 
However the consideration of different ambulance designs, materials and maintenance 
systems are solely not enough to reduce contamination threats.  Equipment used in the 
ambulance, such as stretchers, stair-chairs and backboards are all victims of contamination and 
carriers of pathogens.  It is therefore important to stress the importance of contamination issues 
in the pre-hospital care to EMS equipment manufactures, as presented to Stryker (see Appendix 
I), a medical technology firm based in Kalamazoo, Michigan. 
 There were several limitations to this project, such as having access to only free journal 
articles. When we were conducting our background research using scientific literature, we only 
had access to articles that were free to read online or were available through the university. Also, 
we only examined UVGI devices from a couple manufacturers – a limitation that might not give 
us a clear general picture of what exists on the market today. In addition, the estimates we made 
regarding specifications not given for some of these UVGI devices might have been inaccurate 
or overly simplistic. For the CAD model in the self-cleaning mechanism, the design constructed 
was based mainly off of what we thought would provide adequate cleaning – testing would be 
needed. And even then, extensive research into power or size constraints would be needed. 
Finally, the majority of the work done for this project was purely theoretical – actual testing 
should be done in the ambulance setting to truly investigate viability. 
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Future work for this project might involve attempts to resolve the limitations experienced 
here. For example, comparisons might be made between more than two UVGI device 
manufacturers. Or, actual testing might be conducted, such as testing UVGI in an actual 
ambulance, or constructing a prototype of the cleaning mechanism in an ambulance. Also, 
further work that might be done on this project may include looking into other recommendations 
to prevent contamination in the ambulance, such as looking into materials that actively 
discourage the growth or survival of microorganisms on its surfaces. 
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APPENDICIES 
Appendix A – Levels of Care and Certifications 
Certification Level of Care Examples of Care Given 
First Responder Basic Life Support CPR, AED, splinting, oxygen 
administration, artificial 
ventilation via Bag Valve 
Mask (BVM), Oralpharyngeal 
Airway (OPA) or 
Nasalpharyngeal Airway 
(NPA) Intubation, and 
assistance with a limited 
number of drugs. 
EMT-Basic Basic Life Support CPR, AED, splinting, traction 
splinting, oxygen 
administration, artificial 
ventilation via Bag Valve 
Mask (BVM), Oralpharyngeal 
Airway (OPA) or 
Nasalpharyngeal Airway 
(NPA) Intubation, and 
assistance with a limited 
number of drugs. 
EMT-Intermediate Advanced Life Support CPR, AED, splinting, traction 
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splinting, oxygen 
administration, artificial 
ventilation via Bag Valve 
Mask (BVM), Oralpharyngeal 
Airway (OPA) or 
Nasalpharyngeal Airway 
(NPA) Intubation, IV therapy 
preparation, manual 
defibrillation, cardiac rhythm 
interpretation, and orotracheal 
intubation and assistance with 
certain drugs. 
EMT-Paramedic Advanced Life Support CPR, AED, splinting, traction 
splinting, oxygen 
administration, artificial 
ventilation via Bag Valve 
Mask (BVM), Oralpharyngeal 
Airway (OPA) or 
Nasalpharyngeal Airway 
(NPA) Intubation, IV therapy 
preparation, manual 
defibrillation, cardiac rhythm 
interpretation, and orotracheal 
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intubation, needle 
cricothyroidotomy, needle 
decompression for tension 
pneumothorax and many 
medication therapies. 
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Appendix B – UVGI Lamp Specifications 
Lamp 
Length 
Lamp 
Model 
Lamp 
Description Type UV Lamps Lamp Base 
UV 
Output 
UV 
Intensity
µW/cm² 
@1m
6" 
GML370 Hot Cathode Lamp PL-S9W/TUV PL-S 
2.4W 
UV - 
GML180 Hot Cathode Lamp G 4T5 T5/mini bi-pin 
0.5W 
UV 5.4 
GML170 Hot Cathode Lamp OZ4T5 T5/mini bi-pin 
0.5W 
UV 5.4 
9" 
GML195 Hot Cathode Lamp G 6T5 T5/mini bi-pin 
1.0W 
UV 11 
GML190 Hot Cathode Lamp OZ 6T5 T5/mini bi-pin 
1.1W 
UV 11 
12" 
GML205 Hot Cathode Lamp G 8T5 T5/mini bi-pin 
1.6W 
UV 17 
GML125 Slimline Lamp G12T5-1/2L/BP T5/mini bi-pin 
6.0W 
UV 66 
GML075 Slimline Lamp G12T5-1/2VH/BP T5/mini bi-pin 
6.0W 
UV 66 
GML405 High Output Lamp GPH357T5L/HO Four-pin 
8.5W 
UV 92 
14" 
AAWHO/14 High Output Lamp GML600 Four-pin 12W UV 106 
UV Bulb 
HO 
High Output 
Lamp UVHOAL300AV/14 Four-pin 12W UV 106 
16" 
GML020 Cold Cathode Lamp 782 L 10 T5/single-pin 
2.8W 
UV 28 
GML120 Cold Cathode Lamp 782 VH 10 T5/single-pin 
2.8W 
UV 28 
GML060 Slimline Lamp G10T5-1/2L T5/single-pin 
5.3W 
UV 55 
GML350 Slimline Lamp G10T5-1/2L-4P T5/four-pin 
5.3W 
UV 55 
GML070 Slimline Lamp G10T5-1/2VH T5/single-pin 
5.3W 
UV 55 
GML430 High Output Lamp GSL406T5L/HO Four-pin 
10.0W 
UV 108 
18" GML210 Hot Cathode G15T8 T8/medium 3.6W 38 
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Lamp bi-pin UV 
TUV15T8* Germicidal G15T8 T8/medium bi-pin 
3.6W 
UV 38 
GML215 Hot Cathode Lamp G25T8 
T8/medium 
bi-pin 
5.0W 
UV 54 
GML410 High Output Lamp GSL406T5L/HO Single-pin 
10.0W 
UV 100 
22" HOAL/22 High Output Lamp GPH550T5/HO Four-pin 
18.1W 
UV 174 
24" GML435 High Output Lamp GPH610T5L/HO Four-pin 
16.2W 
UV 175 
27" 
GML025 Cold Cathode Lamp 782 L 20 T5/single-pin 
5.5W 
UV 52 
GML290 Cold Cathode Lamp 782 VH 20 T5/single-pin 
5.5W 
UV 52 
GML325 Slimline Lamp GSL591 T5/single-pin - - 
GML355 Slimline Lamp S24T5-4P T5/four-pin - - 
GML415 High Output Lamp GSL610T5L/HO Single-pin 
16.2W 
UV 140 
30" GML030 Cold Cathode Lamp 782 L 25½ T5/single-pin 
7.3W 
UV 75 
36" 
GML010 Cold Cathode Lamp 782 L 30 T5/single-pin 
8.3W 
UV 73 
GML035 Cold Cathode Lamp 782 VH 29 T5/mini bi-pin 
9.1W 
UV 80 
GML040 Cold Cathode Lamp 782 VH 30 T5/single-pin 
5.2/8.3W 
UV 46 / 73 
GML220 Hot Cathode Lamp G30T8 
T8/medium 
bi-pin 
8.3W 
UV 85 
GML005 Slimline Lamp G36T6L T5/single-pin 
13.8W 
UV 120 
GML100 Slimline Lamp G36T6L-4P T5/four-pin 
12.7W 
UV 110 
GML090 Slimline Lamp G36T6VH T5/single-pin 
13.8W 
UV 120 
GML095 Slimline Lamp G37T6VH T5/single-pin 
15.2W 
UV 124 
GML420 High Output GSL843T5L/HO Single pin 25.0W 195 
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Lamp UV 
GML440 High Output Lamp GSL843T5L/HO/4 Four-pin 
25.0W 
UV 195 
48" 
GML425 High Output Lamp GSL1148T5L/HO Single pin 
36.1W 
UV 250 
GML445 High Output Lamp GSL1148T5L/HO/4 Four-pin 
36.1W 
UV 250 
60" 
SLR32143 HO Amalgam Lamp 
TUV 260W 
XPTDIM Four-pin 
93W 
UVC 650 
SLR32143 
HP 
HO Amalgam 
Lamp TUV335WXPT Four-pin 
93W 
UVC 650 
61" 
GA64T6 HO Amalgam Lamp GIA1564T6LCA 
Two-step, 4-
pin 
75W 
UVC 600 
G64T5L UV Lamp TUV64T52PSE 4-pin     
64" 
GML017 High Output Lamp GXO64T5L H/O Single-pin 
46.0W 
UV 370 
GML015 Slimline Lamp G64T5L T5/single-pin 
26.7W 
UV 190 
GML140 Slimline Lamp G64T5VH T5/single-pin 
26.7W 
UV 190 
GML270 Slimline Lamp G64T5L-4P T5/four-pin 
26.7W 
UV 190 
 
* Philips 15W, Sterilamp® T-8 Fluorescent Lamp, Medium Bi-pin Base. Germicidal UV-C for 
air disinfection applications. Compatible: Ionic Breeze GP UV air purifier. 
Table obtained from American Air and Water, Inc. 
(http://www.americanairandwater.com/uv-lamps.htm)  
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Appendix C – UV Dosage Table 
Organisms: Energy Dosage of Ultraviolet radiation (UV 
dose) in µWs/cm2 needed for kill factor 
Bacteria 90% (1 log reduction) 
99% 
(2 log reduction) 
Bacillus anthracis - Anthrax 4,520 8,700 
Bacillus anthracis spores - Anthrax spores 24,320 46,200 
Bacillus magaterium sp. (spores) 2,730 5,200 
Bacillus magaterium sp. (veg.) 1,300 2,500 
Bacillus paratyphusus 3,200 6,100 
Bacillus subtilis spores 11,600 22,000 
Bacillus subtilis 5,800 11,000 
Clostridium tetani 13,000 22,000 
Corynebacterium diphtheriae 3,370 6,510 
Ebertelia typhosa 2,140 4,100 
Escherichia coli 3,000 6,600 
Leptospiracanicola - infectious Jaundice 3,150 6,000 
Microccocus candidus 6,050 12,300 
Microccocus sphaeroides 1,000 15,400 
Mycobacterium tuberculosis 6,200 10,000 
Neisseria catarrhalis 4,400 8,500 
Phytomonas tumefaciens 4,400 8,000 
Proteus vulgaris 3,000 6,600 
Pseudomonas aeruginosa 5,500 10,500 
Pseudomonas fluorescens 3,500 6,600 
Salmonella enteritidis 4,000 7,600 
Salmonela paratyphi - Enteric fever 3,200 6,100 
Salmonella typhosa - Typhoid fever 2,150 4,100 
Salmonella typhimurium 8,000 15,200 
Sarcina lutea 19,700 26,400 
Serratia marcescens 2,420 6,160 
Shigella dyseteriae - Dysentery 2,200 4,200 
Shigella flexneri - Dysentery 1,700 3,400 
Shigella paradysenteriae 1,680 3,400 
Spirillum rubrum 4,400 6,160 
Staphylococcus albus 1,840 5,720 
Staphylococcus aureus 2,600 6,600 
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Staphylococcus hemolyticus 2,160 5,500 
Staphylococcus lactis 6,150 8,800 
Streptococcus viridans 2,000 3,800 
Vibrio comma - Cholera 3,375 6,500 
Molds 90% 99% 
Aspergillius flavus 60,000 99,000 
Aspergillius glaucus 44,000 88,000 
Aspergillius niger 132,000 330,000 
Mucor racemosus A 17,000 35,200 
Mucor racemosus B 17,000 35,200 
Oospora lactis 5,000 11,000 
Penicillium expansum 13,000 22,000 
Penicillium roqueforti 13,000 26,400 
Penicillium digitatum 44,000 88,000 
Rhisopus nigricans 111,000 220,000 
Protozoa 90% 99% 
Chlorella Vulgaris 13,000 22,000 
Nematode Eggs 45,000 92,000 
Paramecium 11,000 20,000 
Virus 90% 99% 
Bacteriopfage - E. Coli 2,600 6,600 
Infectious Hepatitis 5,800 8,000 
Influenza 3,400 6,600 
Poliovirus - Poliomyelitis 3,150 6,600 
Tobacco mosaic 240,000 440,000 
Yeast 90% 99% 
Brewer’s yeast 3,300 6,600 
Common yeast cake 6,000 13,200 
Saccharomyces carevisiae 6,000 13,200 
Saccharomyces ellipsoideus 6,000 13,200 
Saccharomyces spores 8,000 17,600 
Table obtained from American Air and Water, Inc. 
(http://www.americanairandwater.com/uv-facts/uv-dosage.htm)  
Appendix D – UVGI Product Specification
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Appendix E – Ambulance CAD Drawing b
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